ザルトリウス・ジャパン List of Products and Services

In recent years, the development of monoclonal antibodies (mAb) as therapeutic agents has garnered attention. mAb is highly anticipated for the treatment of severe diseases such as cancer and other conditions that are difficult to treat. One reason for this is not only their high efficacy and low side effects but also their high specificity of response. Vaccines and effective antibody therapeutics play an essential role in suppressing the ongoing COVID-19 pandemic and newly emerging variants. Neutralizing antibodies are one example of molecules that play a decisive role in the development of vaccines and therapeutics, as they can bind to viruses and prevent infection. Neutralizing antibodies can be isolated from the plasma of recovered patients, and researchers worldwide are focusing on them to deepen the understanding of the mechanism of action (MOA) against the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. *You can download the English version of the catalog. *For more details, please refer to the PDF materials or feel free to contact us.

Chimeric antigen receptor T cell (CAR-T) therapy uses genetically modified T cells to fight cancer and holds the potential to revolutionize the medical landscape. However, it is challenging for researchers developing cell-based therapies to explore the complex immune system, especially when using traditional screening and profiling methods. Recently, advancements in assay technology have begun to significantly change the drug discovery and development of CAR-T. These technological advancements have enabled high-throughput, cost-effective analyses that provide speed and sensitivity, yielding deeper biologically relevant information and allowing for the rapid acquisition of practical results. *You can download the English version of the catalog. *For more details, please refer to the PDF materials or feel free to contact us.

This document introduces "Resolving the Bottlenecks in Data Analysis with iQue Forecyt Software." It includes "Comparison of Workflows," "Simple and Intuitive Experiment and Data Acquisition Setup," and "Powerful Data Analysis and Visualization Tools." This software allows you to obtain practical information to advance research topics more quickly than flow-based solutions. We encourage you to read it. 【Contents (partial)】 ■ Interactive assay development and analysis, and visualization of multi-parameter data ■ Comparison of workflows ■ Forecyt configuration options - expandable according to needs ■ Simple and intuitive experiment and data acquisition setup ■ Powerful data analysis and visualization tools *For more details, please refer to the PDF document or feel free to contact us.

This document presents the workflow and data for quantifying multiple AAV serotypes using the Octet AAVX biosensor on the Octet BioLayer Interferometry (BLI) label-free detection platform, facilitated by a simple direct quantification assay design. It also describes the main features and advantages of the AAVX biosensor. We encourage you to read this as a reference for product introduction. [Contents (excerpt)] ■ Summary ■ Introduction ■ Reagents and Testing Procedures ■ Matrix Interference Testing ■ Correlation between Octet AAVX Assay and ELISA *For more details, please refer to the PDF document or feel free to contact us.